DIETARY SUPPLEMENTS
Découvrez 08 - Slim
Your ally for a slimmer figure and healthy weight
Journal
They are everywhere.
Peptides. Copper peptides. Signal peptides. Matrixyl. GHK-Cu. Argireline. Collagen peptides.
Over the past few years, peptides have become one of the most prominent categories of anti-aging skincare ingredients. Serums, moisturizers, eye creams, and dietary supplements now promise to stimulate collagen production, firm the skin, reduce wrinkles, support fibroblasts, or even “communicate” with skin cells.
The trend has become so significant that a scientific review published in 2025 identified 102 commercially available cosmetic peptides, associated with claims as diverse as stimulating collagen and hyaluronic acid, modulating pigmentation, providing antioxidant activity, influencing the skin microbiome, inhibiting neurotransmitters, or transporting trace elements [1].
But behind a single word — peptide — lies an extraordinarily diverse group of molecules.
A peptide that carries copper does not work like a peptide inspired by a fragment of collagen.
A peptide designed to influence fibroblast activity does not work like one intended to interfere with neurotransmitter release.
And most importantly:
A peptide that is biologically active in a Petri dish is not necessarily capable of crossing intact human skin and producing a visible anti-aging effect.
That may be the single most important distinction to understand amid the current peptide boom.
Because peptide science is real.
The question is not whether peptides can have biological activity. Many of them can.
The more demanding question is:
Can a peptide in a skincare product remain stable, penetrate the skin sufficiently, reach its biological target at an effective concentration, and produce a clinically measurable improvement in the signs of skin aging?
To answer that question, we first need to understand what a peptide actually is.
A peptide is a molecule composed of a sequence of amino acids linked together by peptide bonds.
Amino acids are the fundamental building blocks our bodies use to make peptides and proteins.
In very simplified terms:
amino acids → peptides → proteins
But the difference is not simply about size.
The sequence of amino acids matters enormously.
A peptide made of three, five, or six amino acids arranged in a specific order can have a very different biological function from another peptide containing the same amino acids arranged in a different sequence.
That sequence can influence:
This is why talking about “peptides” as a single ingredient category is almost like talking about “proteins” or “vitamins” without specifying which ones.
Not all peptides do the same thing.
An amino acid is an individual molecular building block.
When several amino acids are connected by peptide bonds, they form a chain that can be described as a peptide.
When these chains become longer and fold into complex three-dimensional structures capable of performing specific biological functions, they are generally described as proteins.
There is, however, no perfectly universal dividing line between a “large peptide” and a “small protein.”
What matters most in dermatology is that short amino-acid sequences can have biological activity of their own.
They are not simply incomplete pieces of proteins.
Some can behave as genuine molecular messengers.
The human body is in constant communication.
A cell needs to receive information from other cells and from its surrounding environment.
It needs to know when to:
divide,
differentiate,
migrate,
secrete specific molecules,
respond to an injury,
initiate or regulate an inflammatory response,
or participate in tissue repair.
Part of this communication relies on biologically active peptides.
Certain peptides can interact with receptors or other molecular targets and modify intracellular signaling cascades.
In other words, a peptide can sometimes function less like a building material and more like information.
That concept is precisely what has made peptides so compelling in cosmetic research.
Rather than simply placing a substance on the surface of the skin, could short peptide sequences be used to send biological signals to skin cells?
This is where the promise of anti-aging peptides begins.
To understand what peptides might be able to change, we first need to understand what changes in aging skin.
Skin aging results from the interaction of two broad processes:
intrinsic aging, associated with time and internal biological processes;
and
extrinsic aging, associated particularly with ultraviolet radiation, pollution, smoking, and other environmental exposures.
Together, these processes progressively affect the epidermis, dermis, vasculature, pigmentation, and extracellular matrix.
Visible manifestations can include:
But what we see at the surface reflects biological changes taking place much deeper within the skin.
And one of the most important structures involved is located in the dermis.
Cells do not simply float freely within our tissues.
They exist within a complex molecular architecture known as the extracellular matrix, or ECM.
In the dermis, the extracellular matrix contains:
Collagen contributes substantially to the mechanical strength of the dermis.
Elastic fibers contribute to its elastic properties.
But the extracellular matrix is not simply a passive scaffold.
It is a biologically active environment that continuously interacts with the cells embedded within it.
And one of the most important cells in this environment is the fibroblast.
Fibroblasts are major cells of the dermal connective tissue.
They participate in the synthesis, organization, and remodeling of many components of the extracellular matrix.
They therefore play a central role in producing and maintaining collagen, elastin, and other structural components of the dermis.
But a fibroblast is not simply a “collagen factory.”
Its behavior depends on the signals it receives from its environment.
Fibroblasts can modify their activity in response to mechanical, inflammatory, metabolic, and molecular signals.
As skin ages — particularly through photoaging — the fibroblast’s environment changes.
The extracellular matrix progressively becomes fragmented and disorganized, while the balance between the synthesis and degradation of its components is altered.
This is where one of the fundamental ideas behind peptide science emerges:
What if certain peptides could act as signals capable of modifying fibroblast activity?
This is one of the central concepts behind signal peptides.
And the idea did not emerge out of nowhere.
When a protein in the extracellular matrix is broken down, it can release peptide fragments.
Some of these fragments are not biologically inert.
They can have signaling activity of their own.
These bioactive fragments derived from extracellular matrix proteins are known, among other terms, as matrikines [1,2].
Certain matrikines can influence processes involved in:
This leads to a particularly elegant biological concept:
The breakdown of the matrix can itself generate signals telling the tissue that remodeling may be needed.
This biological principle inspired several peptides now used in cosmetic formulations.
A matrikine is a bioactive fragment derived from a protein in the extracellular matrix.
It can be released when that protein is degraded and may subsequently interact with surrounding cells.
We can think of the extracellular matrix as an architecture that also contains its own communication system.
When that architecture is altered or broken down, certain fragments may become molecular messages.
This concept is particularly important for understanding so-called biomimetic cosmetic peptides.
The goal is to identify a biologically interesting peptide sequence and create a molecule capable of reproducing or mimicking some of its properties.
In theory:
matrix fragment → biological signal → fibroblast → cellular response → matrix remodeling.
It is an exceptionally compelling concept.
But between that theoretical mechanism and a visibly reduced wrinkle in human skin, several additional steps have to occur.
The term biomimetic means that a molecule has been designed to mimic a naturally occurring biological structure or function.
Many cosmetic peptides are inspired by sequences found in the human body or by known biological mechanisms [1].
The goal may be to mimic:
But biomimetic does not automatically mean effective.
A molecule can accurately reproduce an interesting biological sequence in the laboratory and still fail to reach its target once incorporated into a topical skincare product.
That distinction will remain important throughout this article.
Classifications vary slightly across the scientific literature, but topical anti-aging peptides have traditionally been divided into four major categories according to their proposed mechanism of action [2,3]:
This classification is useful for one simple reason:
It immediately reminds us that not all peptides are trying to accomplish the same biological goal.
Signal peptides are probably the category most directly associated with anti-aging claims surrounding collagen production.
They are designed to reproduce or mimic biological signals that may influence skin cells.
Some are inspired by fragments of extracellular matrix proteins.
The theoretical goal is to send fibroblasts a signal that promotes specific processes related to extracellular matrix synthesis or remodeling.
This category includes some of the best-known cosmetic peptides associated with the Matrixyl family.
One historically well-studied example is palmitoyl pentapeptide-4, also known by the sequence pal-KTTKS.
In a randomized, double-blind, vehicle-controlled, split-face study, 93 women between the ages of 35 and 55 applied either a control moisturizer or the same moisturizer containing 3 ppm pal-KTTKS for 12 weeks [4].
The peptide-treated side showed significantly greater improvement in fine lines and wrinkles than the vehicle-treated side, based on quantitative image analysis and expert assessment [4].
That is meaningful human evidence.
But it does not demonstrate that all signal peptides work, nor does it mean that every product containing a peptide from the Matrixyl family will necessarily reproduce the results obtained with that specific formulation.
We will explore signal peptides and Matrixyl in depth in a separate article.
Carrier peptides follow a different biological logic.
Their proposed role is to bind and transport specific molecules or trace elements with biological functions.
The most famous example today is probably:
GHK-Cu — glycyl-L-histidyl-L-lysine complexed with copper.
Copper is involved in the activity of several enzymes and biological processes related to connective tissue, antioxidant defense, and tissue repair.
The concept behind a carrier peptide is therefore to bind or transport an element into a biological environment where it may participate in specific functions.
Interest in copper peptides has become enormous.
But once again, our dedicated article will need to distinguish between:
what is biologically plausible;
what has been observed in vitro or in tissue-repair models;
and
what has actually been demonstrated in human skin aging.
GHK-Cu therefore deserves an entire article of its own in this series.
This third category has probably generated some of the most spectacular marketing claims.
Neurotransmitter-inhibiting peptides are designed to interfere with certain mechanisms associated with neurotransmission.
The best-known example is:
acetyl hexapeptide-8, also known as Argireline.
Its proposed mechanism has led to the now widespread expression:
“Botox in a bottle.”
The idea is compelling: influence mechanisms associated with the muscular contractions involved in expression lines without injecting botulinum toxin.
But it immediately raises a major pharmacological problem.
To work according to that proposed mechanism, the peptide must not only possess biological activity — it must also reach a sufficiently deep target after being applied to the surface of the skin.
Yet scientific literature has specifically highlighted the limited permeability of acetyl hexapeptide-8 through the stratum corneum and the uncertainty surrounding its ability to reach deeper biological targets after topical application [5].
We will therefore dedicate an entire article to the question:
Can a “Botox-like” peptide really behave like Botox if it cannot effectively reach the muscle?
Enzyme-inhibiting peptides are designed to modulate the activity of specific enzymes involved in skin biology.
Depending on the peptide and target being investigated, these may include mechanisms associated with the degradation of structural proteins, pigmentation, or other cutaneous processes [1–3].
Again, this is a very broad category.
Two peptides classified as enzyme inhibitors may target entirely different enzymes and have very little else in common.
This is why simply seeing the word “peptide” on an ingredient list tells us almost nothing about what a product is actually designed to do.
We need to know:
the specific peptide, its sequence, its concentration, its formulation, its target, and the scientific evidence supporting it.
A biologically interesting peptide is not necessarily a good cosmetic ingredient.
It may be:
too hydrophilic,
too unstable,
too easily degraded,
unable to cross the stratum corneum efficiently,
or unable to reach its biological target at a sufficient concentration.
One strategy is therefore to chemically modify the peptide.
Palmitoylation is a classic example.
Adding a lipid chain can alter the peptide’s physicochemical properties and increase its lipophilic character.
This is what we see, for example, with:
KTTKS → palmitoyl-KTTKS.
But improving a molecule’s properties still does not guarantee that it will successfully reach the dermis.
And this brings us to the central problem in topical peptide skincare.
The skin is specifically designed to prevent the uncontrolled entry of substances from the outside world.
Its primary barrier lies in the outermost portion of the epidermis:
the stratum corneum.
This layer forms an extraordinarily effective interface between the body and its environment.
It limits the penetration of many hydrophilic and larger molecules.
And many peptides have exactly the characteristics that make skin penetration difficult.
A review dedicated to anti-wrinkle peptides summarized the issue clearly: most anti-wrinkle peptides are not naturally ideal candidates for transdermal penetration, even though many of their proposed biological targets lie in deeper layers of the skin [6].
More recent reviews of peptides in skin aging likewise identify poor membrane permeability as one of the major limitations of cosmetic peptides [2].
The stratum corneum consists of corneocytes organized within a highly structured lipid matrix.
This architecture creates an efficient diffusion barrier.
A molecule’s ability to cross that barrier depends on factors including:
The diffusion of highly hydrophilic molecules, including many peptides, is particularly challenging.
This is a critical point.
When a laboratory study shows that a peptide stimulates a fibroblast in cell culture, the peptide is placed directly in contact with its target.
In a facial serum, it must first navigate:
formulation → stability → skin surface → stratum corneum → enzymatic degradation → diffusion through skin layers → cellular target.
Those are two radically different biological situations.
This may be the most important rule for interpreting peptide research.
The experiment takes place outside a living organism — for example, using fibroblasts grown in a laboratory.
It can answer a question such as:
“What happens when this peptide is placed directly in contact with fibroblasts?”
That is extremely useful for understanding a mechanism.
But it does not demonstrate that the peptide can reach those fibroblasts from the surface of intact human skin.
The experiment uses biological tissue removed from an organism and studied outside the body.
For example, researchers may evaluate how a compound penetrates through samples of human skin.
This brings the experiment closer to physiological reality.
But the tissue is no longer functioning as part of an intact living organism.
The intervention is studied in a living organism — and, for the question that matters here, ideally in humans.
Researchers can then measure:
wrinkles,
hydration,
elasticity,
texture,
density,
tolerability,
or other clinical and instrumental outcomes.
When evaluating an anti-aging claim intended for humans, well-designed controlled human trials are ultimately the evidence that matters most.
Because the challenge is not necessarily impossible to overcome.
Formulation science is specifically designed to improve peptide stability and delivery.
Strategies being investigated or used include:
Skin-penetrating peptides have become a research field in their own right, with the goal of facilitating the transport of molecules across the skin barrier [8].
Nanoparticle systems and other delivery strategies are also being investigated to improve the cutaneous bioavailability of peptides [9].
This leads to an essential conclusion:
The effectiveness of a peptide skincare product may depend as much on its formulation as on the peptide itself.
Two serums listing the exact same peptide on their ingredient labels may therefore not necessarily provide the same skin bioavailability.
No.
An INCI list may tell you that a peptide is present.
It generally cannot tell you precisely:
This distinction has become particularly important as skincare products increasingly advertise cocktails containing:
5 peptides
8 peptides
10 peptides
or more.
The number of peptides in a formula is not, by itself, a measure of efficacy.
More peptides do not necessarily mean more biological activity.
A 2025 review identifying 102 commercially available cosmetic peptides illustrates the scale of the current phenomenon [1].
The authors identified peptides associated with a remarkably broad range of proposed activities:
But it is important to look closely at what the publication actually assessed.
It focused largely on the in vitro and ex vivo evidence available for these peptides [1].
And the authors identified highly variable levels of supporting evidence.
In other words:
102 peptides on the market do not mean 102 peptides whose anti-aging efficacy has been demonstrated in large randomized clinical trials in humans.
That distinction is crucial.
We now have a sufficiently recent meta-analysis to begin answering that question seriously.
A systematic review and meta-analysis published in 2026 analyzed 19 randomized controlled trials involving 1,341 participants [10].
Researchers examined the effects of peptides administered orally or topically on several parameters associated with skin aging, including:
Overall, peptide interventions were associated with improvements in hydration and radiance, as well as a modest pooled effect on wrinkles [10].
At first glance, that sounds highly encouraging.
But the data require much closer examination.
The overwhelming majority of participants in this meta-analysis received oral formulations, primarily collagen-derived peptides.
Evidence specifically involving topical peptides was far more limited [10].
It would therefore be scientifically inaccurate to turn this meta-analysis into a claim such as:
“19 randomized trials prove that peptide serums reduce wrinkles.”
That is not what the evidence shows.
And this is precisely where the most interesting part of the investigation begins.
For a cosmetic peptide to produce a genuine anti-aging effect, several conditions have to be met.
It needs to be:
biologically relevant;
present at a sufficient concentration;
stable within the formulation;
available after application;
capable of crossing the necessary biological barriers;
capable of reaching its target;
and ultimately:
capable of producing an effect large enough to be measured in humans.
It is a chain.
And breaking a single link may be enough to prevent a mechanism that looks compelling on paper from becoming a visible result on the skin.
That is why the real question is not:
“Do peptides work?”
It is:
“Which peptides, in which formulations, at what concentrations, delivered where, and supported by what level of evidence?”
In Part 2, we move from biological plausibility to what ultimately matters: human clinical evidence.
What do the studies actually show about wrinkles?
Hydration?
Elasticity?
Dermal density?
Do topical peptides outperform the vehicle they are formulated in?
Is there a dose-response relationship?
How long does it take to see results?
Can different peptides be combined?
How do peptides compare with retinol, retinoids, and vitamin C?
And most importantly:
Is the current peptide craze proportionate to the strength of the scientific evidence?
Part 1 explored why peptides have become so compelling in cosmetic science.
The biological concept is particularly attractive: use short amino-acid sequences as signals, carriers, or modulators of specific cellular functions to influence skin biology.
But a plausible biological mechanism is not the same thing as clinical proof.
For a peptide to become genuinely relevant in anti-aging skincare, we need evidence that a product containing it can actually improve human skin.
This is where the hierarchy of evidence becomes essential.
An experiment on fibroblasts may tell us that a peptide can stimulate a specific biological mechanism.
A penetration study may show that some amount of the peptide can cross certain layers of the skin.
But only a properly designed clinical trial can begin to answer the question consumers actually care about:
Does this peptide reduce wrinkles, improve hydration, increase elasticity, or meaningfully affect other signs of skin aging in humans?
A systematic review and meta-analysis published in 2026 provides one of the most comprehensive recent assessments of the clinical literature [10].
Researchers included 19 randomized controlled trials involving 1,341 participants.
They evaluated several parameters associated with skin aging, including:
Overall, peptide interventions were associated with significant improvements in skin hydration and radiance, as well as a modest pooled reduction in wrinkles [10].
For wrinkles, the pooled mean difference was 0.27, with a p value of 0.04 [10].
At first glance, these findings seem particularly encouraging.
But they need to be interpreted carefully.
Under the broad term “peptides,” the meta-analysis combined two biologically very different approaches:
oral peptides
and
topical peptides.
And the overwhelming majority of participants received oral formulations, primarily collagen-derived peptides [10].
That substantially changes how these results should be interpreted.
We cannot simply take the overall results of this meta-analysis and apply them directly to a topical peptide serum.
Topical interventions represented a much smaller proportion of the evidence analyzed [10].
And when the researchers examined wrinkles specifically, the observed effect was largely driven by oral polypeptides.
In other words:
There is clinical evidence supporting certain peptides, but current research does not establish that any serum containing peptides will reduce wrinkles.
This distinction is fundamental.
It also illustrates a common problem in cosmetic communication: evidence generated for one molecule, one formulation, or one route of administration can gradually become generalized to an entire category.
But:
oral peptide ≠ topical peptide
one peptide ≠ all peptides
one formulation ≠ every formulation.
Yes.
One of the most interesting historical trials involved palmitoyl pentapeptide-4 — pal-KTTKS, the signal peptide introduced in Part 1 [4].
The study was randomized, double-blind, vehicle-controlled, and split-face, involving 93 women between the ages of 35 and 55.
For 12 weeks, one side of the face received a control moisturizer while the other received the same moisturizer containing 3 ppm pal-KTTKS [4].
The peptide-containing treatment produced significantly greater improvement in fine lines and wrinkles based on quantitative image analysis and expert assessment [4].
Participants also reported improvements in fine lines and wrinkles.
This is an interesting result because the peptide was compared with the same vehicle without the peptide.
That study design makes it easier to distinguish the potential effect of the peptide from the effects of the moisturizer itself.
But the study also has an important limitation when considering the independence of the evidence: the authors were affiliated with Procter & Gamble, the company involved in developing the technology investigated [4].
That does not invalidate the results.
But industry funding and author affiliations are relevant information when evaluating the overall strength and independence of a scientific evidence base.
Yes.
A randomized, double-blind, placebo-controlled clinical trial published in 2021 investigated a serum designed to target expression lines [11].
Fifty-five women between the ages of 35 and 60 completed the study.
Participants applied either the active serum or a placebo serum twice daily for 12 weeks [11].
Dermatologist assessments and instrumental measurements reported significantly greater improvements with the active serum across several parameters, including fine lines and wrinkles [11].
At eight weeks, for example, 94% of participants in the active group showed improvement in fine lines, with a median improvement of 25%, while 67% showed improvement in wrinkles, with a median improvement of 20% [11].
But once again, the study needs to be read beyond the headline.
The tested product did not contain one isolated peptide.
It combined several peptides with other ingredients, including GABA, botanical extracts, antioxidants, prebiotics, and hyaluronic acid [11].
It is therefore impossible to attribute the entire observed effect to any one peptide.
The study was also funded by the company marketing the product, and several authors were current or former employees of that company [11].
The result remains clinically interesting.
But it demonstrates the performance of that complete formulation under those study conditions, not the efficacy of peptide serums as an entire category.
Because a cream or serum is never simply a container holding an active ingredient.
The vehicle can influence:
It can also produce visible effects of its own.
A vehicle containing humectants or emollients may rapidly improve skin hydration and the appearance of fine lines, independently of any effect on collagen production.
This is why vehicle-controlled studies are particularly valuable.
If the same serum without the peptide already improves the skin, the additional effect actually attributable to the peptide may be considerably smaller than a simple before-and-after photograph suggests.
Not reasonably, if the claim refers to meaningful collagen synthesis and remodeling of the dermal extracellular matrix.
Collagen production, organization, and remodeling are biological processes that take time.
When a product improves the appearance of fine lines within minutes of application, other mechanisms need to be considered:
hydration, film formation on the skin surface, optical effects, temporary changes in texture, or other immediate properties of the formulation.
That does not mean the product is ineffective.
It simply means that an immediate cosmetic effect should not be confused with dermal collagen remodeling.
The 2026 meta-analysis reported a significant improvement in hydration across the pooled peptide interventions [10].
But once again, much of the evidence involved oral formulations.
For topical products, improvements in hydration may also depend heavily on the rest of the formulation.
A peptide cream may simultaneously contain:
glycerin, hyaluronic acid, lipids, silicones, ceramides, or other moisturizing ingredients.
Any increase in hydration should therefore not automatically be attributed to the peptide itself unless the study design allows its specific contribution to be isolated.
Here, the results are less convincing.
The 2026 meta-analysis found inconsistent results for elasticity and certain structural parameters [10].
This matters because peptide marketing frequently uses terms such as:
firming
lifting
collagen boosting
skin density
rebuilding.
These terms imply meaningful structural changes.
Yet current clinical evidence does not establish that topical peptides as a broad category reliably produce clinically meaningful increases in dermal density or elasticity in all users.
No.
This is another critical distinction.
A wrinkle may appear less pronounced for several reasons:
A clinical improvement in wrinkles therefore does not, by itself, prove that:
“This product increased dermal collagen.”
Directly demonstrating a change in collagen requires appropriate methods such as histology, validated biomarkers, imaging techniques, or other structural measurements.
This is precisely one of the areas in which future peptide research needs to become more rigorous [10].
There is no universal timeframe.
It depends on the peptide, its proposed mechanism, formulation, concentration, and the outcome being measured.
The pal-KTTKS study lasted 12 weeks [4].
The 2021 multi-peptide serum trial also evaluated participants over 12 weeks, with assessments at four, eight, and twelve weeks [11].
For mechanisms that are supposed to involve extracellular matrix remodeling, a few days would in any case be an extremely short timeframe.
Claims such as:
“boosts collagen in 24 hours”
should therefore be interpreted carefully when they are used to imply visible structural reconstruction of the dermis.
A change in a laboratory biomarker is not the same thing as clinically meaningful tissue remodeling.
Not necessarily.
Pharmacology does not always follow the rule:
more = better.
A peptide’s activity depends on factors including:
A very high concentration on the surface of the skin does not guarantee an effective concentration within the dermis.
And for some biological mechanisms, once a certain level of activity has been reached, increasing the dose may not produce a proportional increase in effect.
Ideally, dose-response studies are needed to establish an optimal concentration.
For many cosmetic peptides, those data remain insufficient.
Not necessarily.
Peptide stacking has become a popular skincare marketing strategy: the more different peptides a formula contains, the more sophisticated it appears.
But the presence of 10 peptides does not demonstrate that:
The 2025 review identified 102 commercially available cosmetic peptides, with highly variable levels of preclinical evidence [1].
The length of an INCI list is therefore not a measure of scientific quality.
Ten poorly delivered peptides do not automatically outperform one peptide that is appropriately formulated and clinically studied.
In principle, yes, provided the formulation is compatible and well tolerated.
Many skincare products intentionally combine peptides designed around different biological mechanisms.
But the scientific reasoning remains the same.
A combination becomes compelling when it is supported by:
a coherent biological rationale + effective delivery + clinical evidence of benefit.
Simply combining multiple biologically interesting molecules does not prove synergy.
In many cases, yes.
Peptides and retinoids do not necessarily act through the same biological mechanisms and should not automatically be treated as mutually exclusive categories.
But there is a major difference in the amount of evidence available.
Topical retinoids have a much older and substantially larger dermatologic evidence base for photoaging.
Peptides represent a newer and far more heterogeneous field.
There is currently no scientific basis for a general claim that:
“peptides work better than retinol.”
Nor that:
“peptides replace retinoids.”
Instead, they may be considered potentially complementary approaches depending on the formulation, tolerability, and treatment goal.
A direct comparison is equally misleading.
Vitamin C and peptides do not belong to the same biological category and do not operate through identical mechanisms.
Ascorbic acid is involved as a cofactor in collagen biosynthesis and also has antioxidant properties.
Peptides, depending on their sequence, may act as signals, carriers, or modulators of other biological mechanisms.
Asking whether “peptides are better than vitamin C” therefore compares two fundamentally different strategies.
The more useful question is:
Which active has the strongest evidence for the specific outcome you are trying to achieve, in a formulation capable of delivering that active effectively?
In many cases, yes.
There is no general scientific rule stating that all peptides are incompatible with vitamin C or retinoids.
However, individual formulations differ in pH, stability, excipients, and irritation potential.
Recommendations should therefore be based on the specific products involved, not simply on the word “peptide.”
For sensitive skin, layering multiple active ingredients may also increase irritation regardless of whether peptides are present.
A biologically sophisticated skincare routine is not necessarily the routine containing the greatest possible number of actives.
Cosmetic peptides are generally considered well tolerated, and available clinical trials frequently report favorable tolerability [4,10,11].
But that does not mean a peptide product can never cause:
Once again, it is important to distinguish the peptide itself from the finished product.
A reaction to a serum containing peptides does not necessarily mean the peptide caused the reaction.
Potentially, depending on the peptide and formulation.
One practical advantage of peptide products is that some may fit into routines in which more irritating active ingredients are poorly tolerated.
But the word “peptide” does not guarantee that a product will be gentle.
Fragrance, alcohol, preservatives, acids, other active ingredients, and the vehicle itself all influence tolerability.
For reactive skin, the complete formulation matters more than the marketing category printed on the bottle.
Many peptides are used in eye creams and serums because the periorbital area combines several common concerns:
fine lines, expression wrinkles, texture changes, and loss of elasticity.
But efficacy still depends on the specific peptide and formulation.
Products used close to the eyes also require appropriate tolerability.
There is no property shared by all peptides that automatically makes every peptide product suitable for the eye area.
Microneedling temporarily creates microchannels in the skin barrier and can increase the penetration of certain substances.
But this fundamentally changes the situation.
A cosmetic product formulated for application to intact skin is not necessarily designed to be introduced deeper into tissue after the barrier has been intentionally disrupted.
Purity, sterility, excipients, and safety then become particularly important.
Microneedling should therefore not be viewed as a universal way to “make any peptide serum work.”
Transdermal peptide delivery is a genuine field of scientific research, but individual delivery strategies need to be evaluated specifically [6].
Because it creates a paradox.
Several peptides display extremely interesting biological activity when placed directly in contact with their target.
But human skin evolved specifically to prevent external molecules from easily reaching deeper tissues.
A review focused specifically on anti-wrinkle peptide permeability concluded that most anti-wrinkle peptides do not naturally possess the ideal characteristics for sufficient skin penetration [6].
Researchers are therefore exploring multiple solutions:
The future of anti-aging peptides may therefore depend as much on delivery science as on discovering new peptide sequences.
Acetyl hexapeptide-8 — commonly associated with the trade name Argireline — perfectly illustrates the issue.
Its proposed mechanism is associated with processes involved in acetylcholine release and, consequently, the muscular contractions that contribute to certain expression lines.
But skin penetration studies show exactly why formulation matters [12].
A study involving researchers from the U.S. Food and Drug Administration investigated the skin penetration of acetyl hexapeptide-8 from a cosmetic formulation using human cadaver skin and an animal model [12].
The findings illustrate the challenges involved in getting a peptide molecule through the different layers of the skin.
Other researchers have attempted to chemically modify Argireline analogs specifically to improve their skin penetration [13].
The very fact that researchers are modifying peptide structure to improve delivery demonstrates how central penetration is to potential efficacy.
We will examine this in much greater detail in our dedicated article on Argireline and “Botox-like” peptides.
The most scientifically accurate answer is:
Some peptides, in some formulations, have evidence suggesting clinical efficacy.
But “peptides” is far too broad a category to validate or dismiss as a whole.
We have:
strong biological mechanisms for certain peptides;
convincing in vitro findings for several molecules;
ex vivo evidence involving penetration or activity for certain formulations;
a number of interesting controlled clinical trials;
but also:
enormous molecular heterogeneity,
significant penetration challenges,
very different formulations,
concentrations that are often difficult for consumers to determine,
relatively small clinical trials,
and a meaningful proportion of research funded by industry.
The science is therefore promising, but far less uniform than peptide marketing often suggests.
What we know reasonably well:
More robust research is still needed to determine:
Current evidence does not establish that:
The word reprogram should therefore remain a scientific question — not become a marketing claim.
Probably a little of both.
Peptides represent a genuinely fascinating area of science.
The idea that a short amino-acid sequence can behave as biological information and influence cellular behavior changes the way we can think about skincare.
We are no longer talking only about moisturizing the surface of the skin.
We are asking whether it is possible to communicate with its biology.
But that molecular sophistication also creates ideal conditions for marketing.
A complex peptide sequence, an impressive cellular mechanism, and an image of a fibroblast are not enough to prove that a serum reduces wrinkles.
Scientific rigor means following the entire chain:
molecule → stability → penetration → target → mechanism → tissue → clinical outcome.
If one of those links is missing, the demonstration remains incomplete.
The next generation of cosmetic peptides may look very different from what we know today.
Research is already exploring:
The goal may not be to put an ever-increasing number of peptides into a serum.
Instead, the real question may become:
What signal should we send, to which cell, at what concentration — and how do we get it there?
It is this convergence of molecular biology and delivery science that could transform peptides from an extremely fashionable skincare category into genuine precision tools for skin biology.
Peptides are neither a marketing invention nor a universal anti-aging solution.
They are biologically fascinating molecules, some of which can act as signals, carriers, or modulators of cellular processes involved in skin structure and function.
Research shows that certain peptides can influence fibroblasts, the extracellular matrix, and biological mechanisms associated with skin aging [1–3].
A number of controlled human trials also suggest that certain topical formulations can improve wrinkles and other aspects of skin quality [4,11].
But the current enthusiasm still exceeds the amount of clinical evidence available for peptides as an entire category.
The 2025 review identifying 102 commercially available cosmetic peptides is particularly revealing: the molecular landscape is vast, but the evidence supporting those molecules remains highly heterogeneous [1].
The 2026 meta-analysis tells an equally important story: 19 randomized trials and 1,341 participants now constitute a meaningful body of clinical research, but favorable findings are largely driven by orally administered peptides, while evidence specifically supporting topical peptides remains much more limited [10].
The question is therefore no longer:
“Do peptides work?”
That question is too broad to be scientifically meaningful.
Instead, we need to ask:
Which peptide?
Which sequence?
At what concentration?
In what formulation?
With what level of skin penetration?
Targeting what biological mechanism?
And most importantly: supported by what evidence in humans?
Answering those questions will determine which peptides truly belong to the next generation of anti-aging skincare — and which, for now, remain fascinating molecules accompanied by fascinating promises.
Peptides are short chains of amino acids. Some peptides can act as signaling molecules or interact with biological mechanisms involved in skin structure, repair, and function.
Certain peptides have been shown to influence fibroblasts and mechanisms associated with the extracellular matrix in experimental models [1–3]. Some signal peptides also have human clinical data [4]. This does not mean that every peptide increases collagen production in human skin.
Certain topical peptide formulations have reduced wrinkles in controlled clinical trials [4,11]. However, the clinical evidence is considerably smaller than the enormous number of peptide skincare products currently available.
There is no universal timeframe. Several clinical studies of topical peptide products have assessed outcomes over approximately 12 weeks [4,11]. Timing depends on the peptide, formulation, concentration, and intended biological effect.
Some peptides can penetrate to some degree, but skin permeability is a major challenge for many peptide molecules. Molecular size, hydrophilicity, charge, chemical modification, formulation, and delivery technology can all influence penetration [6,12,13].
No. The number of peptides in a product is not a validated measure of efficacy. Concentration, stability, bioavailability, mechanism of action, formulation, and clinical evidence matter more than the number printed on the packaging.
In many cases, yes. Peptides and retinoids can act through different biological mechanisms. Tolerability nevertheless depends on the specific formulations and individual skin sensitivity.
Current evidence does not support that general conclusion. Retinoids have a substantially larger body of evidence for photoaging, while peptides represent a much more heterogeneous group of molecules.
There is no universal incompatibility between all peptides and all forms of vitamin C. Compatibility depends on the specific peptide, vitamin C derivative, pH, stability, and formulation.
Some peptide products may be well tolerated by sensitive skin, but tolerability depends on the complete formula. Fragrance, alcohol, preservatives, acids, and other active ingredients can all affect skin sensitivity.
In cosmetic science, signal peptides are designed to mimic or exploit biological sequences capable of influencing cellular communication. Some are intended to affect fibroblast activity and extracellular matrix remodeling.
Copper peptides are peptides capable of complexing copper. GHK-Cu is the best-known example and is commonly associated with the cosmetic ingredient copper tripeptide-1. Its biology and clinical evidence will be explored in a dedicated Journal article.
Matrixyl is a commercial family of peptides used in anti-aging skincare formulations. Some Matrixyl peptides are inspired by sequences associated with extracellular matrix signaling and fibroblast biology. Their mechanisms and clinical evidence will be examined in a dedicated article.
Argireline is the trade name commonly associated with acetyl hexapeptide-8, a peptide designed around a mechanism related to neurotransmission. It is often described as “Botox-like,” but its mechanism, skin penetration, and clinical effects are fundamentally different from those of botulinum toxin [12,13].
Not in the sense of globally reversing the biological age of the skin. Certain peptides can influence specific signaling pathways or cellular behaviors. “Reprogramming” should therefore not be interpreted as scientifically demonstrated reversal of overall skin aging.
This article is the starting point of our series exploring the science of peptides.
Next, we will take a deeper look at three peptide categories currently generating some of the greatest interest in skincare:
GHK-Cu & Copper Peptides — Can Copper Really Regenerate the Skin?
Matrixyl & Signal Peptides — Can We Tell Fibroblasts to Produce More Collagen?
Argireline & “Botox-Like” Peptides — Botox in a Bottle?
Because behind the single word “peptide” lie radically different biological mechanisms — and equally different levels of scientific evidence.
A Doctor of Pharmacy and expert in Predictive & Preventive Medicine, Dr. ESPINASSE has spent more than 20 years developing an integrative approach connecting nutrition, metabolism, the microbiome, cellular function, aging, and longevity.
Her clinical experience with more than 20,000 patients, informed by more than 15,000 in-depth assessments, led her to develop Cellular Nutrition®: an approach that considers nutrients and bioactive compounds through the physiological and cellular mechanisms they are intended to support.
Through METHODE ESPINASSE, Dr. ESPINASSE translates more than two decades of clinical experience into targeted nutritional protocols designed around health, beauty, longevity, and healthy aging from within.
[1] van Walraven N, FitzGerald RJ, Danneel HJ, Amigo-Benavent M. Bioactive peptides in cosmetic formulations: Review of current in vitro and ex vivo evidence. Peptides. 2025;193:171440. DOI: 10.1016/j.peptides.2025.171440. PMID: 40946970.
URL: https://pubmed.ncbi.nlm.nih.gov/40946970/
[2] Sirois JP, Heinz A. Matrikines in the skin: Origin, effects, and therapeutic potential. Pharmacology & Therapeutics. 2024;260:108682. DOI: 10.1016/j.pharmthera.2024.108682. PMID: 38917886.
URL: https://pubmed.ncbi.nlm.nih.gov/38917886/
[3] Skibska A, Perlikowska R. Signal Peptides — Promising Ingredients in Cosmetics. Current Protein & Peptide Science. 2021;22(10):716–728. DOI: 10.2174/1389203722666210812121129. PMID: 34382523.
URL: https://pubmed.ncbi.nlm.nih.gov/34382523/
[4] Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science. 2005;27(3):155–160. DOI: 10.1111/j.1467-2494.2005.00261.x. PMID: 18492182.
URL: https://pubmed.ncbi.nlm.nih.gov/18492182/
[5] Lupo MP, Cole AL. Cosmeceutical peptides. Dermatologic Therapy. 2007;20(5):343–349. DOI: 10.1111/j.1529-8019.2007.00148.x. PMID: 18045359.
URL: https://pubmed.ncbi.nlm.nih.gov/18045359/
[6] Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. PMID: 35302659.
URL: https://pubmed.ncbi.nlm.nih.gov/35302659/
[7] Pai VV, Bhandari P, Shukla P. Topical peptides as cosmeceuticals. Indian Journal of Dermatology, Venereology and Leprology. 2017;83(1):9–18. DOI: 10.4103/0378-6323.186500. PMID: 27451932.
URL: https://pubmed.ncbi.nlm.nih.gov/27451932/
[8] El Hadmed HH, Castillo RF. Cosmeceuticals: peptides, proteins, and growth factors. Journal of Cosmetic Dermatology. 2016;15(4):514–519. DOI: 10.1111/jocd.12229. PMID: 27142709.
URL: https://pubmed.ncbi.nlm.nih.gov/27142709/
[9] Lim SH, Sun Y, Madanagopal TT, Rosa V, Kang L. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Scientific Reports. 2018;8:1596. DOI: 10.1038/s41598-017-18454-z. PMID: 29371611.
URL: https://pubmed.ncbi.nlm.nih.gov/29371611/
[10] Nukaly HY, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 2026. PMID: 41924746.
URL: https://pubmed.ncbi.nlm.nih.gov/41924746/
[11] Nguyen TQ, Zahr AS, Kononov T, Ablon G. A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines. Journal of Clinical and Aesthetic Dermatology. 2021;14(5):14–21. PMID: 34188744. PMCID: PMC8211334.
URL: https://pubmed.ncbi.nlm.nih.gov/34188744/
[12] Kraeling MEK, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutaneous and Ocular Toxicology. 2015;34(1):46–52. DOI: 10.3109/15569527.2014.894521. PMID: 24754410.
URL: https://pubmed.ncbi.nlm.nih.gov/24754410/
[13] Lim SH, Sun Y, Madanagopal TT, Rosa V, Kang L. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Scientific Reports. 2018;8(1):1596. DOI: 10.1038/s41598-017-18454-z. PMID: 29371611.
URL: https://pubmed.ncbi.nlm.nih.gov/29371611/
[14] Peptides as Master Keys to Skin Aging. 2025. DOI: 10.1159/000547734. PMID: 40875756.
URL: https://pubmed.ncbi.nlm.nih.gov/40875756/
